Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0S9AY
|
||||
| Former ID |
DNC009143
|
||||
| Drug Name |
1-(2-(6-fluoronaphthalen-2-yl)ethyl)piperazine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530012] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H19FN2
|
||||
| Canonical SMILES |
C1CN(CCN1)CCC2=CC3=C(C=C2)C=C(C=C3)F
|
||||
| InChI |
1S/C16H19FN2/c17-16-4-3-14-11-13(1-2-15(14)12-16)5-8-19-9-6-18-7-10-19/h1-4,11-12,18H,5-10H2
|
||||
| InChIKey |
AVSJNVNTDDYDEP-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [530012] | |
| Sodium-dependent serotonin transporter | Target Info | Inhibitor | [530012] | ||
| Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [530012] | ||
| KEGG Pathway | Serotonergic synapse | ||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PathWhiz Pathway | Muscle/Heart Contraction | ||||
| WikiPathways | SIDS Susceptibility Pathways | ||||
| Hematopoietic Stem Cell Differentiation | |||||
| Potassium ChannelsWP727:Monoamine Transport | |||||
| NRF2 pathway | |||||
| Synaptic Vesicle Pathway | |||||
| Serotonin Transporter ActivityWP727:Monoamine Transport | |||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.